Categories: Health

Transactions under Novonesis share buyback program

Novonesis has now completed the announced share buyback program of B shares worth up to EUR 100 million (DKK 746 million) in total during 2025. As of June 27th, 2025, Novonesis has purchased an accumulated  1,729,099 shares with a transaction value of DKK 745,2 million under the share buyback program announced by Novonesis in Company announcement No. 3, 2025 and initiated on March 5, 2025.

Please read the full announcement in PDF.

Attachment

GlobeNews Wire

Recent Posts

AvironiX Unveils AviSpray-10c, a Backpack-Sized Agricultural Spraying Drone for India’s Precision Farming Sector

CHENNAI, India, Dec. 8, 2025 /PRNewswire/ -- AvironiX Drones, a Chennai-based deep-tech drone company focused on precision farming and defence technologies, today…

1 hour ago

Abstract and Open World Partner to Launch the First National-Scale Tokenization Engine for the World’s Most Valuable Real-World Assets

For the first time, the world's most strategic assets—AI supercomputing centers, strategic real estate and…

1 hour ago

Navitas, Cyient Semiconductors enter into a strategic partnership to accelerate GaN adoption in India’s AI, Mobility, Industrial, and Energy Markets

TORRANCE, Calif. and HYDERABAD, India, Dec. 8, 2025 /PRNewswire/ -- Navitas Semiconductor Corporation (Nasdaq: NVTS),…

1 hour ago

DXC Appoints Russell Jukes as Chief Digital Information Officer to Strengthen Unified Digital Strategy

ASHBURN, Va., Dec. 8, 2025 /PRNewswire/ -- DXC Technology (NYSE: DXC), a leading enterprise technology and…

1 hour ago

Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI

Latest release enables faster, more confident design decisions at scale with accelerated simulation, AI-powered, real-time…

1 hour ago

Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025

– New findings demonstrate a 72% HI-E response rate at Week 16 with meaningful hemoglobin…

1 hour ago